Aug 30, 2011|
Dr. George Demetri stops by to talk with John and Gerry and discusses what he does on a daily basis to cure this deadly disease. The doctor also talks about some clinical trials, new advances in personalized medicine and where we are headed in the field of cancer research.
Transcript - will not be 100% accurate
Welcome back my friends this is the WEEI -- and Jimmy Fund radio telephone from Fenway Park 8777381234. You can also -- log on to Jimmy Fund dot org or log on to. W -- dot com slash Jimmy Fund or AT&T is really made it easy for you. You can text K cancer all one word -- cancer to 20222. Looking -- on the bill insurance -- -- reported 2191094. Dollars and every gift makes a difference from ten dollars to 5000 dollars you can become a Jimmy -- all star. If you make gift of 15100 dollars or more it's an exclusive club I'll announce your name. Take a bow to all star will be announced on there all -- -- truly make a difference for adults and children currently battling cancer 8777381234. Where Jimmy -- -- it more. Proposals to Marion alana and Lisa sure we a lot of guys that desperate that to Medina and the two of them the two of them are just the greatest the face. That what they do at the clinic case of the -- when you have Nick Leeson the -- prevalent in the patient and the star of the show. I'm. What more we could say you know no. If that as a movie to pick up the phone -- make a donation I don't know what would -- doctor George Dmitri is the senior vice president for experimental therapeutics. You know you of a very tough act to follow after a lot of I don't know that in -- -- -- these different do the opposite. Telling him what tell me what what experimental therapeutics are what do you do adopt a daily basis to help -- the dreaded disease. Well basically what we do is try to come up with new drugs that work better than the ultra -- years and years ago 1020 years ago and my parents were battling cancer. All we had were things that we found by hit or miss extracts from. You know plant leaves some dirt specimens that might kill some cancer cells but in the process hats -- side effects -- pretty impressive. Nowadays we understand much more about what's driving cancer where the short circuits where the wires crossed. And how could we develop drugs. That specifically shut off the circuits and are safe for the rest of the -- how the process get so much more efficient in the last ten or fifteen or twenty years you know we've learned so much more because of the war on cancer this thing going on since the early 1970s the investment this country in the world let's put into the science of understanding. Biology understanding cancer cells is finally able to be translated into new and effective drugs. That are safe pills that aren't so. Difficult to take that this sort of dreaded intravenous infusions all the time that -- people to come into the clinic so much more fun for music doctor. To see my patients to get McHale. And then just haven't come back once a month once every three months read it and see him every week when need to go through a lot of side. We who doctor that Roland said to us earlier in twenty years Google news you'll get rid of cancer but it -- -- -- bill. And it's control it's like. Avalon is trying to upstage again it but it did it that's that's -- two big event a horrible. Expect that really possible is that fairy tale it. It's really possible because we're already doing it with certain diseases certain kinds of leukemia and certain kinds of intestinal cancers literally I've been following some of my patients the last eleven years. Who would have been dead. Eleven years ago will not stand for this hill. That sort of started this revolution this one pill called -- back. Which was just the first of the match last week the FDA approved a new medicine for about 5% of people with lung cancer the week before that. They proved another pill for about six out of ten people have a type of melanoma. I mean these are untreatable cancers before and now it's coming fast and furious I think it's absolutely reality and it's our job Dana Farber. With the support of the very generous people in New England. To make that a reality we're all in this together. And right at a time when the economy's not great. And the government doesn't have a lot of money to put into the kind of research that we're doing it's more important than ever so that we can really bring this to the people that matter people in our own lives. Doctor to be too much of what you'd do deals with clinical trial it's correct correct. A great deal what you do it is their percentage of the book when you're ready to go to clinical trial obviously you're not necessarily confident but hopeful that this is going to be. And upgraded some former fashion with a -- fewer side effects were more efficient treatment. How often do they work out the way you want them to 10% 50% 80% what yet the old number. With one at a 1010%. Would actually succeed a horrible number up you know who would bet on that unit you bet a 110. That's terrible right -- nowadays if we use the science are trials are hopefully -- that more like 400 to 500. And it's a real predictive factor if we can predict what's gonna work and I can look at pace in the eye and say you know if you were my relative. I would absolutely enter this trial because the science says this should. Have a really good chance for working with you and that's with patients listened to become the Dana Farber for that kind of hope. And they trust us to use the science for their own benefit and this is happening right over there is happening right here in America right over the horizon lab coats are coming up -- medicine to. Cure cancer absolutely. And we're not doing it alone were part of whole international consortium this is some of which is coming out of universities like Harvard Dana Farber is the cancer node at Harvard University so we will reach into the expertise of the chemistry department at Harvard or if we needed. MIT's in counseling a lot of collaborations with them we have collaborations in Australia and France and China you name it we will use where we need -- to try to bring things to people. How much deuce side effects negative side effects impact and delay cures -- -- if you could wave a magic wand and said we can invent what we -- invent. And if there weren't side effects it would be bad. Would you be a lot further down the road. You know not really no cancer look at the drugs we've traditionally is twenty years ago side effects of traditional cancer chemotherapy were pretty bad right now in fact. In medicine there's some of the worst side effects of any medicines used to treat anything. So the fact is we started with a pretty well you know -- -- to implement the new drugs are much better tolerated these new pills. That make it's a little bit of trouble handing for example you know that's and I -- that well but again if it's saving your life it's something we're. Dealing yet specifically right now on this date would you really excited about and when you come back here next year you might have a good story to tell us we. Are so excited about lots of delays now we've just taken first baby steps towards doing that we will develop one drug for one disease but now we're starting to mix and match the drugs and that's where. I would actually be a little bit more optimistic even in chief scientific officer I still have cured my sites if we start to mix and match. These drugs once their FDA approved individually. I think curable com. By mixing them together into what is -- by personalized medicine the personalized medicine is simply understanding an individual's cancer and matching the right drug for that person. But that's matching one drug to one person if we say here's one person but now we need three different drugs yes and we wanna pick the right three for that person. That's will hopefully lead to more -- and that's that's hard to do. But that's why we have all the scientists were so good work you guys stumble across cures like I mean today maybe some cure a hangover something -- and hey -- The Viagra story how you record high blood pressure medicine and look what it sounds that -- noses and little involvement veteran. That don't work sometimes. Stumble across secure for something the only exactly in other words there's this one -- this until I mentioned before it was developed really it's something for the heart in workers' art -- -- -- really helps it make people with leukemia live longer and treat systemic that's -- technically live there. And it's a bunch of them. He -- doctor George -- senior vice president for experimental therapeutics thank you for the work you do think -- in time to talk with us today to thank you for -- -- -- -- 8777381234. -- -- -- -- -- all stars -- role -- -- -- these people donated. A lot of money including 15100 dollars we have 2500 dollars from heavily win Newcastle. New Hampshire about several aspect about. Mike Ribeiro -- mass 15100. Dollars John -- from South Weymouth. 15100. Dollars Jennifer Whitney -- -- a thousand dollars William Paul wall and 1000 dollars to take a bow thank you so much. -- now 8777381234. Gives other updated -- would meter. The RL insurance or is it 2191094. But that's -- -- -- violent movement alright this is the WEEI -- Jimmy -- radio telethon. Live from Fenway --
Patriots LB, Jerod Mayo, talks about the high praise he's been receiving from coach Belichick, trying to forget about last year, and what the team hopes from the defense.
Patriots WR, Danny Amendola, joined the show for a bit to talk about his health, the evolution of the playbook, and the heated battles between the offense and defense.
WEEI.com's Mike Petraglia and Chris Price discuss Wednesday's Patriots practice, which featured Brandon Browner getting into it with Kenbrell Thompkins and a couple others.
Jackie Mac joins the guys to discuss her thoughts on a possible mid-season tournament in the NBA, LeBron's return to Cleveland, trade rumors with the Celtics and Red Sox, and Darrelle Revis' contract situation.
Jackie MacMullan of ESPN Boston to talk about the Lebron James Saga, the possibility of Rajon Rondo being traded, and the future of Marcus Smart.
Former coach of Celtics 1st-round pick Marcus Smart, Travis Ford joins MFB to talk about what Celtics fans should expect from the strong point guard. Among other things, Coach Ford says Smart will be a hard worker, and will improve his shooting ability.
Rob and Alex talk with John Farrell about all the moves the Red Sox made at the deadline, what they gave up and what they gained.
Rob Bradford and Alex Speier are in and talking about all the moves made by the Red Sox at the trade deadline, because the most fun thing about the day is talking about the moves of the day. Red Sox GM Ben Cherington held a press conference talking about the Red Sox moves, and Rob and Alex talk with Red Sox manager John Farrell about the moves made at the deadline.
Former Red Sox outfielder Jonny Gomes reacts to the news that he, along with Jon Lester, have been traded to the Oakland Athletics for Yoenis Cespedes
Rob Bradford is joined by WEEI.com Bruins beat writer DJ Bean, as well as Boston sports fan/blogger Turtleboy to talk all things Bruins free agency. With the B's recent moves, the conversation turns to where the Bruins might next turn and what kind of dent losing Jarome Iginla and Shawn Thornton might make.
DJ discusses Shawn Thornton's new deal, and the on going negotiations with Jerome Iginla
DJ Bean joins the program to dismiss the recent rumors that the Bruins are in discussions to trade Brad Marchand to the Sharks for Patrick Marleau
The top stories of the day as recounted by John Dennis.
John, Gerry and Meter react to the breaking news of Jon Lester being dealt to the A's.
ESPN Boston's Gordon Edes gave us the latest on the Lester trade talks.
Lou goes through the 5 stages of grief, then John Lackey gets traded to the Cardinals.
Lou, Christian, and Tim react to the news that Jon Lester and Jonny Gomes have been traded to Oakland for Yoenis Cespedes. Lou hates the deal the move, especially because Cespedes is not arbitration eligible.
Former Red Sox outfielder Jonny Gomes joins MFB to react to the news he has been traded along with Jon Lester to the Oakland Athletics for Yoenis Cespedes
Biggest trade deadline day in recent memory for the Boston Red Sox... and not in a good way. We discuss it all as the news happens and take your reactions.
We tackle four topics, all surrounding the four worst Sox trade deadline deals in recent memory.
As news looms about a possible Jon Lester trade, we sit down with the skipper of your Sox live from Fenway park.
Mut and Villani are talking about whether the Red Sox will give Jon Lester the type of contract he is looking for, or whether they might be shopping him with rumors of the Red Sox scouting Cole Hamels.
Mut and Villani are talking about the MLB All Star Game, Adam Wainwright and Derek Jeter, and what are some of the worst ideas in sports.
Sam and Zach discuss changing the format of the Podcast, the Chris Archer-David Ortiz debacle, and LeBron James being a super genius
Particularly in a year where the Red Sox have struggled while trying to integrate numerous young players into regular big league roles, accusations that Red Sox prospects are overrated -- whether by the team or writers -- have been widespread. Jim Callis of MLB.com joins the show to take stock of the matter, and to discuss the team-building impact of overrating and underrating prospects.
With the trade deadline looming, the next few days will be defined by how teams value prospects -- and their potential long-term contributions -- against big leaguers with established track records who can address immediate needs. Are prospects being valued accurately? Red Sox left-hander Andrew Miller -- once one of the two key chips that sent Miguel Cabrera from the Marlins to the Tigers -- assesses the matter.
ESPN Boston's Gordon Edes gave us the latest on the Lester trade talks.More from this show
Lou, Christian, and Tim react to the news that Jon Lester and Jonny Gomes have been traded to Oakland for Yoenis Cespedes. Lou hates the deal the move, especially because Cespedes is not arbitration eligible.More from this show
Former Red Sox outfielder Jonny Gomes joins MFB to react to the news he has been traded along with Jon Lester to the Oakland Athletics for Yoenis CespedesMore from this show
Lou goes through the 5 stages of grief, then John Lackey gets traded to the Cardinals.More from this show